Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia Gravis

Condition:   Myasthenia Gravis Intervention:   Drug: CD19 CAR-T cells injection Sponsor:   Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials